| Transcriptomic analysis identifies RNA binding proteins as putative regulators of myelopoiesis and leukemia S Saha, KC Murmu, M Biswas, S Chakraborty, J Basu, S Madhulika, ... Frontiers in oncology 9, 692, 2019 | 19 | 2019 |
| Differential colitis susceptibility of Th1-and Th2-biased mice: A multi-omics approach S Mukhopadhyay, S Saha, S Chakraborty, P Prasad, A Ghosh, P Aich PloS one 17 (3), e0264400, 2022 | 13 | 2022 |
| PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy PG Miller, AS Sperling, C Mayerhofer, M McConkey, JM Ellegast, ... Blood Journal, blood. 2023020331, 2023 | 6 | 2023 |
| MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway‐induced p53‐dependent apoptosis V Suresh, P Dash, S Suklabaidya, KC Murmu, PK Sasmal, GM Jogdand, ... The FASEB Journal 36 (8), e22449, 2022 | 3 | 2022 |
| SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms S Saha, P Samal, S Madhulika, KC Murmu, S Chakraborty, J Basu, ... Blood Advances 6 (10), 3106-3113, 2022 | 3 | 2022 |
| Molecular and epigenetic alterations in normal and malignant myelopoiesis in human leukemia 60 (HL60) promyelocytic cell line model J Basu, S Madhulika, KC Murmu, S Mohanty, P Samal, A Das, ... Frontiers in Cell and Developmental Biology 11, 1060537, 2023 | 2 | 2023 |
| SUPPLEMENTAL APPENDIX SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms S Saha | | |
